Evaluates obesity prevalence in nephrology patients, highlighting age and COVID-19 impacts.
Background: Excess body weight is a major global health problem and an established independent risk factor for chronic kidney disease (CKD). This study aimed to determine the prevalence of overweight and obesity and to evaluate sex-, age-, and time-related trends—including the COVID-19 period—among patients treated at the Outpatient Clinic of the Division of Nephrology, Dialysis and Arterial Hypertension, University Hospital of Split, from 2016 to 2024. Methods: This study included 3033 subjects over 18 years of age, 44.8% men and 55.2% women with a mean age of 60 years. Body composition was assessed using the Tanita MC-780 bioelectrical impedance analyzer and body mass index (BMI, kg/m2) was measured. Results: The study population had median BMI of 28.0 kg/m2, with 33.1% overweight and 37% obese participants, including 6.6% with class III obesity. Men showed greater muscle and bone mass (p < 0.001), whereas women had higher fat mass and obesity prevalence (38.2% vs. 35.6%, p < 0.001). Participants under 65 years had higher absolute fat and muscle mass but similar fat percentage compared to older adults. Overweight and obesity prevalence increased with age, peaking at 75–78% in the 55–74-year group. BMI and fat mass rise significantly during and after the COVID-19 period, while phase angle values declined. Conclusions: Excess body weight is highly prevalent in nephrology patients, particularly in middle-aged adults. The COVID-19 pandemic further worsened body composition indicators, reinforcing the need for preventive strategies.
No takes yet. Share an insight, caveat, or question.
Radić et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: